Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed partial-onset seizures
2009-011135-13Phase 3Completed
- Sponsor
- BIAL
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy and Focal Onset Epilepsy comparing Eslicarbazepine acetate monotherapy with Controlled-release carbamazepine monotherapy (2 arms). Started May 2010; status: completed.
02
Drugs
eslicarbazepine acetatecarbamazepine
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on 2009-011135-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011135-13.